72 Investment Holdings, LLC Long-Term Concentrated

CIK: 0001832749 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $39,788 (100.0% shares, 0.0% debt)

Holdings (7)

LENZ LENZ THERAPEUTICS INC 44.2%

Value ($000) $17,597 Shares 1,017,751 Est. Cost $20.79 Unrealized -16.0%

KRRO KORRO BIO INC 23.6%

Value ($000) $9,376 Shares 276,831 Est. Cost $32.95 Unrealized +67.7%

ANRO ALTO NEUROSCIENCE INC 17.9%

Value ($000) $7,139 Shares 667,778 Est. Cost $15.65 Unrealized -16.8%

PRAX PRAXIS PRECISION MEDICINES I 6.9%

Value ($000) $2,727 Shares 65,933 Est. Cost $18.01 Unrealized +162.4%

— TURNSTONE BIOLOGICS CORP 3.6%

Value ($000) $1,441 Shares 549,980 Est. Cost $3.94 Unrealized —

CRBU CARIBOU BIOSCIENCES INC 2.0%

Value ($000) $777 Shares 474,067 Est. Cost $24.45 Unrealized -86.9%

— OMEGA THERAPEUTICS INC 1.8%

Value ($000) $731 Shares 352,941 Est. Cost $18.85 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LENZ	LENZ THERAPEUTICS INC	1,017,751	$17,597	44.2%	$20.79	-16.0%	COM	52635N103
KRRO	KORRO BIO INC	276,831	$9,376	23.6%	$32.95	+67.7%	COM	500946108
ANRO	ALTO NEUROSCIENCE INC	667,778	$7,139	17.9%	$15.65	-16.8%	COM SHS	02157Q109
PRAX	PRAXIS PRECISION MEDICINES I	65,933	$2,727	6.9%	$18.01	+162.4%	COM NEW	74006W207
—	TURNSTONE BIOLOGICS CORP	549,980	$1,441	3.6%	$3.94	—	COM	90042W100
CRBU	CARIBOU BIOSCIENCES INC	474,067	$777	2.0%	$24.45	-86.9%	COM	142038108
—	OMEGA THERAPEUTICS INC	352,941	$731	1.8%	$18.85	—	COMMON STOCK	68217N105